ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges. Herzog SK, Fuqua SAW. Br J Cancer 2021 Oct 7. pii: 10.1038/s41416-021-01564.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Herzog SK, Fuqua SAW. ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges. Br J Cancer 2021 Oct 7. pii: 10.1038/s41416-021-01564.
PMID: 34621045